RevitalVision: How It Works, Cost, Evidence, Alternatives

Updated

What is RevitalVision?

RevitalVision is software that you use at home on a computer. The FDA device listing names Talshir Guy Medical Technologies Ltd., based in Israel, as the manufacturer. The company's site lists Yair Yahav as founder and CEO.

As of October 2026, RevitalVision's site markets separate programs for:

  • Lazy eye (amblyopia) in children over 9 and adults
  • Presbyopia, the age-related loss of close focus, for people starting to rely on reading glasses
  • Mild nearsightedness (low myopia)
  • Vision after cataract surgery or after LASIK
  • Sports vision, for people who already see 20/20
  • Eye diseases and low vision, including nystagmus and keratoconus

How does RevitalVision work?

The program shows Gabor patches, small blurry striped patches that vary in contrast, size and angle, in what the company calls a patented technique. In the published studies, patients tried to detect faint patches, sometimes with other patches nearby, and the task got harder as they improved.

RevitalVision's pages describe the schedule as 30-minute sessions, 3 to 4 times a week. The lazy eye program is 40 sessions over about 3 months. The low myopia, presbyopia and sports programs are 30 sessions over about 2 months. Each program page says an eye care professional monitors training remotely.

You need a computer with internet access, a flat (not curved) screen of 15 to 27 inches and a standard mouse. The FAQ says phones are not suitable. A tablet works only if it is connected to an external screen of that size and a mouse. Before buying, you take an online eligibility test, and the company says the program is not for everyone.

Is RevitalVision FDA cleared?

The FDA device listing for RevitalVision points to one 510(k) clearance, K012530. The FDA cleared it on August 31, 2001, for a device called the AA-1 System from Neurovision, Inc. The FDA classed it as a haploscope, a class I ophthalmic device.

The indication in that record reads: treatment of amblyopia "using an interactive computerized program in patients 9 years or older." The form is marked for prescription use. A 510(k) clearance means the FDA found the device substantially equivalent to devices already on the market. It is not the same as FDA approval.

As of October 2026, we searched the FDA's 510(k) and De Novo databases for RevitalVision, Talshir and NeuroVision. Apart from K012530, we found no FDA clearance for this product, including the low myopia, presbyopia, post-surgery, sports or low vision programs. RevitalVision's site calls it the only FDA-cleared product for amblyopia in people aged 9 and up. That is the company's own statement.

Does RevitalVision work? What the studies found

Early published studies of this program used its earlier name, NeuroVision. RevitalVision lists them, and later studies, among its publications. The table shows what five of these studies did and found, and the company ties each paper states.

Of the five studies in the table, only the 2004 trial was randomized. RevitalVision's publications page also lists later randomized trials of perceptual learning in keratoconus, infantile nystagmus and deprivation amblyopia. To see how clinicians check depth and eye teaming after treatment, see our clinic article on stereoacuity tests.

Published studies of the RevitalVision (NeuroVision) program
StudyDesignWhoResult as reportedCompany ties stated in the paper
Polat 2004, PNASRandomized, masked, controlled (authors' description)77 people aged 9 to 55 with amblyopia in one eye (63 trained, 14 placebo)About 45 sessions on average. 68% of trained patients gained 2 or more chart lines, and contrast sensitivity roughly doubled. Gains mostly held at 12 months.Two authors were former NeuroVision board members with small holdings. The study was supported in part by NeuroVision.
Polat 2009, Vision ResearchPilot study, no control group5 children aged 7 to 8 whose patching had failed or was not toleratedUp to 40 sessions. Vision improved by 1.5 lines on average.Not checked; the full text is not open access
Durrie 2007, Trans Am Ophthalmol SocControlled, not randomizedLow myopia: 11 trained, 6 controls. Early presbyopia: 18 trained, 3 controls30 sessions. Unaided vision improved by 2.2 lines in both trained groups, at distance for myopia and at near for presbyopia. Controls did not change significantly.The lead author was a paid researcher for NeuroVision.
Tan 2008, J Cataract Refract SurgCase series, no control group20 adults aged 19 to 53 with low myopiaUnaided distance vision improved by 2.1 lines on average. Gains were kept up to 12 months.Neither author had a financial interest.
Samant 2026, Clinical OphthalmologyProspective study, no randomized control group73 people, average age 14.6, most after 2+ years of failed patching40 to 80 sessions. Vision improved most in amblyopia from unequal prescriptions. The authors saw a slight trend back toward baseline at 6 to 12 months.One author reported speaker fees from drug companies. The others reported none.

Perceptual learning for amblyopia: independent reviews

Researchers outside the company have reviewed perceptual learning for lazy eye across many programs, not RevitalVision alone.

A 2009 review by Dennis Levi and Roger Li at UC Berkeley reported that people with amblyopia kept their practice gains over time. Gains were usually biggest on the trained eye and task, though practice with varied tasks also carried over to eye chart results.

A 2015 meta-analysis in Investigative Ophthalmology and Visual Science pooled 24 studies of adults who used perceptual learning, dichoptic training or video games. Vision improved by 0.17 logMAR on average, and 32% of people gained 0.2 logMAR (2 chart lines) or more. The type of training made no significant difference. The authors said clinical trials were needed to confirm the findings.

A 2025 meta-analysis pooled 22 randomized trials with 422 adults. Training groups improved more than control groups, and the reviewers rated 78% of the studies as low risk of bias.

The American Association for Pediatric Ophthalmology and Strabismus (AAPOS) states, "treatments we have for amblyopia don't work for adults." It also says treatment started up to about age 14 can still help. Our guide to lazy eye exercises covers patching and home practice in more detail.

RevitalVision cost and who it is for

As of October 2026, RevitalVision does not publish a price. Its FAQ says the cost of the programs varies and that pricing is sent after you pass the eligibility test. Check current pricing with the company. It offers a 14-day money-back guarantee to new customers who buy directly. If you bought through a clinic, the clinic's refund policy applies.

By its own description, the lazy eye program is for children over 9 and adults. The FDA clearance covers amblyopia in patients 9 and older and is marked for prescription use. The other programs are for people with mild nearsightedness, early presbyopia, vision concerns after eye surgery, some eye diseases, or normal vision they want to sharpen. RevitalVision's strengths are a long publication record behind its method, a defined session plan and remote follow-up by an eye care professional.

A full eye exam comes first. Many problems look alike, and the right step depends on the cause. A clinician can also run a binocular vision assessment to see how the two eyes work together.

RevitalVision alternatives compared

AAPOS says glasses help some children with lazy eye, and some also need patching or eye drops. Patching or blurring eye drops are the standard treatments for children. Prescribed dichoptic treatments, where each eye sees a different part of a picture, are newer. Luminopia and CureSight are two FDA-cleared examples for younger children. Our guides to Luminopia alternatives, AmblyoPlay alternatives and Vivid Vision alternatives cover those programs, and our clinic article on VR amblyopia treatment covers the headset trials.

The table lists what each option is. It is not a ranking, and which one fits depends on age, the type of amblyopia and your eye doctor's advice.

RevitalVision and other lazy eye options, as of October 2026
OptionWhat it isAgesPrescriptionFDA status
RevitalVisionPerceptual learning software on a home computer; 40 sessions for lazy eye9 and older (FDA indication)Marked prescription use in the FDA record510(k) K012530 (2001), amblyopia, 9 and older
GlassesCorrects the prescription; often the first stepAll agesYes, from an eye examNot applicable
Patching or atropine dropsCovers or blurs the stronger eyeMainly childrenYes, from an eye doctorNot covered here
LuminopiaPrescribed dichoptic VR treatment using TV shows4 to under 13YesFDA De Novo 2021; cleared for wider ages 2025
CureSightPrescribed dichoptic treatment using videos and an eye tracker4 to under 9YesFDA 510(k) clearance

Where Optics Trainer fits

Optics Trainer is not an alternative to RevitalVision or to any care your clinician prescribes. It is not a perceptual learning program, and it was not part of any study described above. It is a set of game-based vision and brain training apps for iPhone, iPad, Android, web browsers and Meta Quest. It includes eye teaming games with convergence and divergence levels, and binocular games where each eye gets its own target, using red-blue glasses on a phone, tablet or computer, or built in on Meta Quest. Optics Trainer is not a treatment or diagnosis, is not FDA cleared and does not measure anything. Our measurement product, Optics Tracker, is described on our clinic site. For more on training games in general, see our guide to visual brain training.

Optics Trainer is not a substitute for professional diagnosis or prescribed care. Consult your eye care professional for guidance about your specific condition. The phone and tablet apps start with a 7-day free trial, and a free web account includes 3 plays a day. After that, mobile and web access is $14.99 a month or $149.99 a year, and VR access is $19.99 a month or $199 a year after a 7-day free trial.

Frequently asked questions

What is RevitalVision?

RevitalVision is home computer software based on perceptual learning. You practice spotting faint striped patches called Gabor patches in 30-minute sessions. The company sells programs for lazy eye, mild nearsightedness, presbyopia, vision after eye surgery, sports vision and some eye diseases.

Is RevitalVision FDA approved?

Its FDA device listing points to a 510(k) clearance, not an approval: K012530, cleared in 2001 for the AA-1 System for amblyopia in patients 9 and older and marked for prescription use. We found no FDA clearance for its other programs.

How much does RevitalVision cost?

RevitalVision does not list prices on its website. It sends pricing after you complete its eligibility test, and costs vary by program. Check current pricing with the company. New customers who buy directly get a 14-day money-back guarantee.

Does Revital Vision therapy work?

In a 2004 randomized controlled trial of 77 people aged 9 to 55 with lazy eye, 68% of trained patients gained 2 or more chart lines. The other four studies in the table were smaller, and none had a randomized control group. RevitalVision also lists later randomized trials in other eye conditions. Some authors had financial ties to the company, as their papers state.

Can adults use RevitalVision for lazy eye?

The company markets its lazy eye program to adults and children over 9, and its FDA clearance covers patients 9 and older. AAPOS says current amblyopia treatments do not work for adults. Talk with an eye care professional about what is realistic for you.

Can I use RevitalVision on my phone?

No. RevitalVision says phones are not suitable. You need a computer with internet access, a flat 15 to 27 inch screen and a standard mouse. A tablet works only when connected to a screen that size and a mouse.

What are the alternatives to RevitalVision?

For lazy eye, the standard options are glasses, patching and blurring eye drops. Prescribed dichoptic treatments such as Luminopia and CureSight are FDA cleared for younger children. Ask your eye doctor which fits.

Sources

  1. Zhong J, et al. Effects of perceptual learning on deprivation amblyopia in children with limbal dermoid: a randomized controlled trial. J Clin Med. 2022
  2. Hecht I, et al. Efficacy of perceptual learning among patients with infantile nystagmus: a prospective single-blind randomised controlled trial. Br J Ophthalmol. 2026
  3. Tang XH, et al. Vision improvement in keratoconus patients trained with perceptual learning: a randomized controlled trial. Am J Ophthalmol. 2025
  4. RevitalVision. Home and FAQ
  5. RevitalVision. Lazy eye (amblyopia) program
  6. RevitalVision. Low myopia program
  7. RevitalVision. Presbyopia program
  8. RevitalVision. Vision improvement technology
  9. RevitalVision. Scientific publications
  10. US FDA. 510(k) K012530: AA-1 System. 2001
  11. US FDA. K012530 510(k) summary and indications statement. 2001
  12. US FDA. Establishment registration and device listing: RevitalVision
  13. Polat U, et al. Improving vision in adult amblyopia by perceptual learning. Proc Natl Acad Sci U S A. 2004
  14. Polat U, Ma-Naim T, Spierer A. Treatment of children with amblyopia by perceptual learning. Vision Res. 2009
  15. Durrie D, McMinn PS. Computer-based primary visual cortex training for treatment of low myopia and early presbyopia. Trans Am Ophthalmol Soc. 2007
  16. Tan DT, Fong A. Efficacy of neural vision therapy to enhance contrast sensitivity function and visual acuity in low myopia. J Cataract Refract Surg. 2008
  17. Samant M, et al. Perceptual learning therapy using RevitalVision in patching-failed amblyopia: visual outcomes, predictors of response, and durability. Clin Ophthalmol. 2026
  18. Levi DM, Li RW. Perceptual learning as a potential treatment for amblyopia: a mini-review. Vision Res. 2009
  19. Tsirlin I, et al. Behavioral training as new treatment for adult amblyopia: a meta-analysis and systematic review. Invest Ophthalmol Vis Sci. 2015
  20. Ming X, et al. A systematic review and meta-analysis of perceptual learning and video game training for adults with monocular amblyopia. Ophthalmol Ther. 2025
  21. AAPOS. Amblyopia
  22. US FDA. De Novo DEN210005: Luminopia One. 2021
  23. US FDA. 510(k) K243819: Luminopia. 2025
  24. US FDA. 510(k) K221375: CureSight-CS100. 2022

Related guides

Try Optics Trainer's binocular games

In Optics Trainer's binocular games, each eye gets its own target while both stay open: with red-blue glasses on a phone, tablet or computer, or built in on Meta Quest. It is practice, not a treatment. The phone and tablet apps start with a 7-day free trial.

Start free